0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Prilide Antihypertensive Drugs Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-27A12788
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Prilide Antihypertensive Drugs Market Research Report 2023
BUY CHAPTERS

Global Prilide Antihypertensive Drugs Market Research Report 2025

Code: QYRE-Auto-27A12788
Report
May 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Prilide Antihypertensive Drugs Market

Prilide Antihypertensive Drugs Market

The global market for Prilide Antihypertensive Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Prilide Antihypertensive Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prilide Antihypertensive Drugs.
The Prilide Antihypertensive Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prilide Antihypertensive Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prilide Antihypertensive Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Prilide Antihypertensive Drugs Market Report

Report Metric Details
Report Name Prilide Antihypertensive Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Hospital
  • Clinic
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Pfizer, Sanofi, Abbott, Novartis, Changzhou Pharmaceutical, Humanwell Pharmaceutical, Hengcheng Pharmaceutical, Hengwei Pharmaceutical, Zhongfu Pharmaceutical, Likang Pharmaceutical, Changjiang Pharmaceutical, Baiyunshan Pharmaceutical, Poly Pharm, Lukang Group, Baili Pharmaceutical, Huahai Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Prilide Antihypertensive Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Prilide Antihypertensive Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Prilide Antihypertensive Drugs Market report?

Ans: The main players in the Prilide Antihypertensive Drugs Market are Merck, Pfizer, Sanofi, Abbott, Novartis, Changzhou Pharmaceutical, Humanwell Pharmaceutical, Hengcheng Pharmaceutical, Hengwei Pharmaceutical, Zhongfu Pharmaceutical, Likang Pharmaceutical, Changjiang Pharmaceutical, Baiyunshan Pharmaceutical, Poly Pharm, Lukang Group, Baili Pharmaceutical, Huahai Pharmaceutical

What are the Application segmentation covered in the Prilide Antihypertensive Drugs Market report?

Ans: The Applications covered in the Prilide Antihypertensive Drugs Market report are Hospital, Clinic

What are the Type segmentation covered in the Prilide Antihypertensive Drugs Market report?

Ans: The Types covered in the Prilide Antihypertensive Drugs Market report are Captopril, Enalapril, Lisinopril, Fosinopril, Others

Recommended Reports

Hypertension & Heart

Cardiovascular Therapies

Drug Class & Adjacent

1 Prilide Antihypertensive Drugs Market Overview
1.1 Product Definition
1.2 Prilide Antihypertensive Drugs by Type
1.2.1 Global Prilide Antihypertensive Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Captopril
1.2.3 Enalapril
1.2.4 Lisinopril
1.2.5 Fosinopril
1.2.6 Others
1.3 Prilide Antihypertensive Drugs by Application
1.3.1 Global Prilide Antihypertensive Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Prilide Antihypertensive Drugs Market Size Estimates and Forecasts
1.4.1 Global Prilide Antihypertensive Drugs Revenue 2020-2031
1.4.2 Global Prilide Antihypertensive Drugs Sales 2020-2031
1.4.3 Global Prilide Antihypertensive Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prilide Antihypertensive Drugs Market Competition by Manufacturers
2.1 Global Prilide Antihypertensive Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Prilide Antihypertensive Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Prilide Antihypertensive Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prilide Antihypertensive Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prilide Antihypertensive Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prilide Antihypertensive Drugs, Product Type & Application
2.7 Global Key Manufacturers of Prilide Antihypertensive Drugs, Date of Enter into This Industry
2.8 Global Prilide Antihypertensive Drugs Market Competitive Situation and Trends
2.8.1 Global Prilide Antihypertensive Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Prilide Antihypertensive Drugs Players Market Share by Revenue
2.8.3 Global Prilide Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prilide Antihypertensive Drugs Market Scenario by Region
3.1 Global Prilide Antihypertensive Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prilide Antihypertensive Drugs Sales by Region: 2020-2031
3.2.1 Global Prilide Antihypertensive Drugs Sales by Region: 2020-2025
3.2.2 Global Prilide Antihypertensive Drugs Sales by Region: 2026-2031
3.3 Global Prilide Antihypertensive Drugs Revenue by Region: 2020-2031
3.3.1 Global Prilide Antihypertensive Drugs Revenue by Region: 2020-2025
3.3.2 Global Prilide Antihypertensive Drugs Revenue by Region: 2026-2031
3.4 North America Prilide Antihypertensive Drugs Market Facts & Figures by Country
3.4.1 North America Prilide Antihypertensive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prilide Antihypertensive Drugs Sales by Country (2020-2031)
3.4.3 North America Prilide Antihypertensive Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prilide Antihypertensive Drugs Market Facts & Figures by Country
3.5.1 Europe Prilide Antihypertensive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prilide Antihypertensive Drugs Sales by Country (2020-2031)
3.5.3 Europe Prilide Antihypertensive Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prilide Antihypertensive Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Prilide Antihypertensive Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prilide Antihypertensive Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Prilide Antihypertensive Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prilide Antihypertensive Drugs Market Facts & Figures by Country
3.7.1 Latin America Prilide Antihypertensive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prilide Antihypertensive Drugs Sales by Country (2020-2031)
3.7.3 Latin America Prilide Antihypertensive Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prilide Antihypertensive Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Prilide Antihypertensive Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prilide Antihypertensive Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prilide Antihypertensive Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prilide Antihypertensive Drugs Sales by Type (2020-2031)
4.1.1 Global Prilide Antihypertensive Drugs Sales by Type (2020-2025)
4.1.2 Global Prilide Antihypertensive Drugs Sales by Type (2026-2031)
4.1.3 Global Prilide Antihypertensive Drugs Sales Market Share by Type (2020-2031)
4.2 Global Prilide Antihypertensive Drugs Revenue by Type (2020-2031)
4.2.1 Global Prilide Antihypertensive Drugs Revenue by Type (2020-2025)
4.2.2 Global Prilide Antihypertensive Drugs Revenue by Type (2026-2031)
4.2.3 Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Prilide Antihypertensive Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prilide Antihypertensive Drugs Sales by Application (2020-2031)
5.1.1 Global Prilide Antihypertensive Drugs Sales by Application (2020-2025)
5.1.2 Global Prilide Antihypertensive Drugs Sales by Application (2026-2031)
5.1.3 Global Prilide Antihypertensive Drugs Sales Market Share by Application (2020-2031)
5.2 Global Prilide Antihypertensive Drugs Revenue by Application (2020-2031)
5.2.1 Global Prilide Antihypertensive Drugs Revenue by Application (2020-2025)
5.2.2 Global Prilide Antihypertensive Drugs Revenue by Application (2026-2031)
5.2.3 Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Prilide Antihypertensive Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Prilide Antihypertensive Drugs Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Company Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Prilide Antihypertensive Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Company Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Sanofi Prilide Antihypertensive Drugs Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 Abbott
6.4.1 Abbott Company Information
6.4.2 Abbott Description and Business Overview
6.4.3 Abbott Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbott Prilide Antihypertensive Drugs Product Portfolio
6.4.5 Abbott Recent Developments/Updates
6.5 Novartis
6.5.1 Novartis Company Information
6.5.2 Novartis Description and Business Overview
6.5.3 Novartis Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Novartis Prilide Antihypertensive Drugs Product Portfolio
6.5.5 Novartis Recent Developments/Updates
6.6 Changzhou Pharmaceutical
6.6.1 Changzhou Pharmaceutical Company Information
6.6.2 Changzhou Pharmaceutical Description and Business Overview
6.6.3 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.6.5 Changzhou Pharmaceutical Recent Developments/Updates
6.7 Humanwell Pharmaceutical
6.7.1 Humanwell Pharmaceutical Company Information
6.7.2 Humanwell Pharmaceutical Description and Business Overview
6.7.3 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.7.5 Humanwell Pharmaceutical Recent Developments/Updates
6.8 Hengcheng Pharmaceutical
6.8.1 Hengcheng Pharmaceutical Company Information
6.8.2 Hengcheng Pharmaceutical Description and Business Overview
6.8.3 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.8.5 Hengcheng Pharmaceutical Recent Developments/Updates
6.9 Hengwei Pharmaceutical
6.9.1 Hengwei Pharmaceutical Company Information
6.9.2 Hengwei Pharmaceutical Description and Business Overview
6.9.3 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.9.5 Hengwei Pharmaceutical Recent Developments/Updates
6.10 Zhongfu Pharmaceutical
6.10.1 Zhongfu Pharmaceutical Company Information
6.10.2 Zhongfu Pharmaceutical Description and Business Overview
6.10.3 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.10.5 Zhongfu Pharmaceutical Recent Developments/Updates
6.11 Likang Pharmaceutical
6.11.1 Likang Pharmaceutical Company Information
6.11.2 Likang Pharmaceutical Description and Business Overview
6.11.3 Likang Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Likang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.11.5 Likang Pharmaceutical Recent Developments/Updates
6.12 Changjiang Pharmaceutical
6.12.1 Changjiang Pharmaceutical Company Information
6.12.2 Changjiang Pharmaceutical Description and Business Overview
6.12.3 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.12.5 Changjiang Pharmaceutical Recent Developments/Updates
6.13 Baiyunshan Pharmaceutical
6.13.1 Baiyunshan Pharmaceutical Company Information
6.13.2 Baiyunshan Pharmaceutical Description and Business Overview
6.13.3 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.13.5 Baiyunshan Pharmaceutical Recent Developments/Updates
6.14 Poly Pharm
6.14.1 Poly Pharm Company Information
6.14.2 Poly Pharm Description and Business Overview
6.14.3 Poly Pharm Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Poly Pharm Prilide Antihypertensive Drugs Product Portfolio
6.14.5 Poly Pharm Recent Developments/Updates
6.15 Lukang Group
6.15.1 Lukang Group Company Information
6.15.2 Lukang Group Description and Business Overview
6.15.3 Lukang Group Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Lukang Group Prilide Antihypertensive Drugs Product Portfolio
6.15.5 Lukang Group Recent Developments/Updates
6.16 Baili Pharmaceutical
6.16.1 Baili Pharmaceutical Company Information
6.16.2 Baili Pharmaceutical Description and Business Overview
6.16.3 Baili Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Baili Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.16.5 Baili Pharmaceutical Recent Developments/Updates
6.17 Huahai Pharmaceutical
6.17.1 Huahai Pharmaceutical Company Information
6.17.2 Huahai Pharmaceutical Description and Business Overview
6.17.3 Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Huahai Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
6.17.5 Huahai Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prilide Antihypertensive Drugs Industry Chain Analysis
7.2 Prilide Antihypertensive Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prilide Antihypertensive Drugs Production Mode & Process Analysis
7.4 Prilide Antihypertensive Drugs Sales and Marketing
7.4.1 Prilide Antihypertensive Drugs Sales Channels
7.4.2 Prilide Antihypertensive Drugs Distributors
7.5 Prilide Antihypertensive Drugs Customer Analysis
8 Prilide Antihypertensive Drugs Market Dynamics
8.1 Prilide Antihypertensive Drugs Industry Trends
8.2 Prilide Antihypertensive Drugs Market Drivers
8.3 Prilide Antihypertensive Drugs Market Challenges
8.4 Prilide Antihypertensive Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Prilide Antihypertensive Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Prilide Antihypertensive Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Prilide Antihypertensive Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Prilide Antihypertensive Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Prilide Antihypertensive Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Prilide Antihypertensive Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Prilide Antihypertensive Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Prilide Antihypertensive Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Prilide Antihypertensive Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Prilide Antihypertensive Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Prilide Antihypertensive Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Prilide Antihypertensive Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Prilide Antihypertensive Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prilide Antihypertensive Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Prilide Antihypertensive Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Prilide Antihypertensive Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Prilide Antihypertensive Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Prilide Antihypertensive Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Prilide Antihypertensive Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Prilide Antihypertensive Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Prilide Antihypertensive Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Prilide Antihypertensive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Prilide Antihypertensive Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Prilide Antihypertensive Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Prilide Antihypertensive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Prilide Antihypertensive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Prilide Antihypertensive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Prilide Antihypertensive Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Prilide Antihypertensive Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Prilide Antihypertensive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Prilide Antihypertensive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Prilide Antihypertensive Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Prilide Antihypertensive Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Prilide Antihypertensive Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Prilide Antihypertensive Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Prilide Antihypertensive Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Prilide Antihypertensive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Prilide Antihypertensive Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Prilide Antihypertensive Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Prilide Antihypertensive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Prilide Antihypertensive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Prilide Antihypertensive Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Prilide Antihypertensive Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Prilide Antihypertensive Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Prilide Antihypertensive Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Prilide Antihypertensive Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Prilide Antihypertensive Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Prilide Antihypertensive Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Prilide Antihypertensive Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Prilide Antihypertensive Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Prilide Antihypertensive Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Prilide Antihypertensive Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Prilide Antihypertensive Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Prilide Antihypertensive Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Prilide Antihypertensive Drugs Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Pfizer Company Information
 Table 76. Pfizer Description and Business Overview
 Table 77. Pfizer Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Pfizer Prilide Antihypertensive Drugs Product
 Table 79. Pfizer Recent Developments/Updates
 Table 80. Sanofi Company Information
 Table 81. Sanofi Description and Business Overview
 Table 82. Sanofi Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Sanofi Prilide Antihypertensive Drugs Product
 Table 84. Sanofi Recent Developments/Updates
 Table 85. Abbott Company Information
 Table 86. Abbott Description and Business Overview
 Table 87. Abbott Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Abbott Prilide Antihypertensive Drugs Product
 Table 89. Abbott Recent Developments/Updates
 Table 90. Novartis Company Information
 Table 91. Novartis Description and Business Overview
 Table 92. Novartis Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Novartis Prilide Antihypertensive Drugs Product
 Table 94. Novartis Recent Developments/Updates
 Table 95. Changzhou Pharmaceutical Company Information
 Table 96. Changzhou Pharmaceutical Description and Business Overview
 Table 97. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product
 Table 99. Changzhou Pharmaceutical Recent Developments/Updates
 Table 100. Humanwell Pharmaceutical Company Information
 Table 101. Humanwell Pharmaceutical Description and Business Overview
 Table 102. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product
 Table 104. Humanwell Pharmaceutical Recent Developments/Updates
 Table 105. Hengcheng Pharmaceutical Company Information
 Table 106. Hengcheng Pharmaceutical Description and Business Overview
 Table 107. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product
 Table 109. Hengcheng Pharmaceutical Recent Developments/Updates
 Table 110. Hengwei Pharmaceutical Company Information
 Table 111. Hengwei Pharmaceutical Description and Business Overview
 Table 112. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product
 Table 114. Hengwei Pharmaceutical Recent Developments/Updates
 Table 115. Zhongfu Pharmaceutical Company Information
 Table 116. Zhongfu Pharmaceutical Description and Business Overview
 Table 117. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product
 Table 119. Zhongfu Pharmaceutical Recent Developments/Updates
 Table 120. Likang Pharmaceutical Company Information
 Table 121. Likang Pharmaceutical Description and Business Overview
 Table 122. Likang Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Likang Pharmaceutical Prilide Antihypertensive Drugs Product
 Table 124. Likang Pharmaceutical Recent Developments/Updates
 Table 125. Changjiang Pharmaceutical Company Information
 Table 126. Changjiang Pharmaceutical Description and Business Overview
 Table 127. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product
 Table 129. Changjiang Pharmaceutical Recent Developments/Updates
 Table 130. Baiyunshan Pharmaceutical Company Information
 Table 131. Baiyunshan Pharmaceutical Description and Business Overview
 Table 132. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product
 Table 134. Baiyunshan Pharmaceutical Recent Developments/Updates
 Table 135. Poly Pharm Company Information
 Table 136. Poly Pharm Description and Business Overview
 Table 137. Poly Pharm Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Poly Pharm Prilide Antihypertensive Drugs Product
 Table 139. Poly Pharm Recent Developments/Updates
 Table 140. Lukang Group Company Information
 Table 141. Lukang Group Description and Business Overview
 Table 142. Lukang Group Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 143. Lukang Group Prilide Antihypertensive Drugs Product
 Table 144. Lukang Group Recent Developments/Updates
 Table 145. Baili Pharmaceutical Company Information
 Table 146. Baili Pharmaceutical Description and Business Overview
 Table 147. Baili Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 148. Baili Pharmaceutical Prilide Antihypertensive Drugs Product
 Table 149. Baili Pharmaceutical Recent Developments/Updates
 Table 150. Huahai Pharmaceutical Company Information
 Table 151. Huahai Pharmaceutical Description and Business Overview
 Table 152. Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 153. Huahai Pharmaceutical Prilide Antihypertensive Drugs Product
 Table 154. Huahai Pharmaceutical Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Prilide Antihypertensive Drugs Distributors List
 Table 158. Prilide Antihypertensive Drugs Customers List
 Table 159. Prilide Antihypertensive Drugs Market Trends
 Table 160. Prilide Antihypertensive Drugs Market Drivers
 Table 161. Prilide Antihypertensive Drugs Market Challenges
 Table 162. Prilide Antihypertensive Drugs Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Prilide Antihypertensive Drugs
 Figure 2. Global Prilide Antihypertensive Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Prilide Antihypertensive Drugs Market Share by Type: 2024 & 2031
 Figure 4. Captopril Product Picture
 Figure 5. Enalapril Product Picture
 Figure 6. Lisinopril Product Picture
 Figure 7. Fosinopril Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Prilide Antihypertensive Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Prilide Antihypertensive Drugs Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Global Prilide Antihypertensive Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Prilide Antihypertensive Drugs Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Prilide Antihypertensive Drugs Sales (2020-2031) & (K Units)
 Figure 16. Global Prilide Antihypertensive Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 17. Prilide Antihypertensive Drugs Report Years Considered
 Figure 18. Prilide Antihypertensive Drugs Sales Share by Manufacturers in 2024
 Figure 19. Global Prilide Antihypertensive Drugs Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Prilide Antihypertensive Drugs Players: Market Share by Revenue in Prilide Antihypertensive Drugs in 2024
 Figure 21. Prilide Antihypertensive Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Prilide Antihypertensive Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Prilide Antihypertensive Drugs Sales Market Share by Country (2020-2031)
 Figure 24. North America Prilide Antihypertensive Drugs Revenue Market Share by Country (2020-2031)
 Figure 25. United States Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Prilide Antihypertensive Drugs Sales Market Share by Country (2020-2031)
 Figure 28. Europe Prilide Antihypertensive Drugs Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Prilide Antihypertensive Drugs Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Prilide Antihypertensive Drugs Revenue Market Share by Region (2020-2031)
 Figure 36. China Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Prilide Antihypertensive Drugs Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Prilide Antihypertensive Drugs Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Prilide Antihypertensive Drugs Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Prilide Antihypertensive Drugs Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Prilide Antihypertensive Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Prilide Antihypertensive Drugs by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Prilide Antihypertensive Drugs by Type (2020-2031)
 Figure 55. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Prilide Antihypertensive Drugs by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Prilide Antihypertensive Drugs by Application (2020-2031)
 Figure 58. Global Prilide Antihypertensive Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 59. Prilide Antihypertensive Drugs Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart